Desiree van der Kleij is the COO at Viroclinics-DDL and General Manager for Cerba Research in The Netherlands since the merger between both companies in 2021. She has over 15 years of experience in the pharmaceutical and biotech industry. She holds a PhD in Immunology from the Utrecht University & Leiden University Medical Center and a Master in Medical Biology from the Amsterdam University.